SLC5A2 and atherosclerosis: The mechanisms underlying the SGLT2 benefit on atherosclerosis could be multifactorial and due to attenuation of secretion of inflammatory molecules, reduction of macrophage infiltration, improvement of autophagy impairment, and inhibition of endothelial dysfunction (43) out of their glucose-lowering effects (44).